Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Snaith

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
The Plant Journal : for Cell and Molecular Biology|November 1, 1995
FLP recombinase in transgenic plants: constitutive activity in stably transformed tobacco and generation of marked cell clones in ArabidopsisN J Kilby, G J Davies, M R Snaith
Endocrinology, Diabetes & Metabolism Case Reports|January 12, 2021
Multifocal insulinoma secondary to insulinomatosis: persistent hypoglycaemia despite total pancreatectomyJennifer R Snaith, Duncan McLeod, Arthur Richardson, et al.
Gene|December 1, 1995
Multiple cloning sites carrying loxP and FRT recognition sites for the Cre and Flp site-specific recombinasesM R Snaith, J A Murray, C A Boulter
Trends in Genetics : TIG|December 1, 1993
Site-specific recombinases: tools for genome engineeringN J Kilby, M R Snaith, J A Murray
Gene|November 21, 1996
An Escherichia coli system for assay of F1p site-specific recombination on substrate plasmidsM R Snaith, N J Kilby, J A Murray
Archives of Disease in Childhood|May 25, 2004
Bleeding ethicsL D Voss, A N Jeffery, R Snaith, et al.
Diabetes Care|July 24, 2019
Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 6, 2025
Use of Cardioprotective Adjuncts in Type 1 DiabetesJerry R Greenfield, Ruth Frampton, Kellie Millard, et al.
Trends in Endocrinology and Metabolism: TEM|July 3, 2025
Targeting cardiometabolic risk in type 1 diabetes through incretin physiologyRuth Frampton, Samantha Hocking, Jennifer R Snaith, et al.
Trends in Endocrinology and Metabolism: TEM|December 12, 2019
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
The Plant Journal : for Cell and Molecular Biology|November 1, 1995
FLP recombinase in transgenic plants: constitutive activity in stably transformed tobacco and generation of marked cell clones in ArabidopsisN J Kilby, G J Davies, M R Snaith
Endocrinology, Diabetes & Metabolism Case Reports|January 12, 2021
Multifocal insulinoma secondary to insulinomatosis: persistent hypoglycaemia despite total pancreatectomyJennifer R Snaith, Duncan McLeod, Arthur Richardson, et al.
Gene|December 1, 1995
Multiple cloning sites carrying loxP and FRT recognition sites for the Cre and Flp site-specific recombinasesM R Snaith, J A Murray, C A Boulter
Trends in Genetics : TIG|December 1, 1993
Site-specific recombinases: tools for genome engineeringN J Kilby, M R Snaith, J A Murray
Gene|November 21, 1996
An Escherichia coli system for assay of F1p site-specific recombination on substrate plasmidsM R Snaith, N J Kilby, J A Murray
Archives of Disease in Childhood|May 25, 2004
Bleeding ethicsL D Voss, A N Jeffery, R Snaith, et al.
Diabetes Care|July 24, 2019
Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 6, 2025
Use of Cardioprotective Adjuncts in Type 1 DiabetesJerry R Greenfield, Ruth Frampton, Kellie Millard, et al.
Trends in Endocrinology and Metabolism: TEM|July 3, 2025
Targeting cardiometabolic risk in type 1 diabetes through incretin physiologyRuth Frampton, Samantha Hocking, Jennifer R Snaith, et al.
Trends in Endocrinology and Metabolism: TEM|December 12, 2019
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?Jennifer R Snaith, Deborah J Holmes-Walker, Jerry R Greenfield
Pageof 5